Literature DB >> 26888676

Particle-Induced Osteolysis Is Mediated by TIRAP/Mal in Vitro and in Vivo: Dependence on Adherent Pathogen-Associated Molecular Patterns.

Christopher P Bechtel1, Jeremy J Gebhart1, Joscelyn M Tatro1, Endre Kiss-Toth2, J Mark Wilkinson2, Edward M Greenfield3.   

Abstract

BACKGROUND: Proinflammatory signaling by toll-like receptors (TLRs) likely contributes to biologic responses to wear particles causing aseptic loosening. We recently reported associations with aseptic loosening in patients with polymorphisms in the locus encoding an adapter protein specific for TLR-2 and TLR-4 known as toll/interleukin-1 receptor domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal). To directly examine the contribution of TIRAP/Mal, we tested the hypothesis that TIRAP/Mal deficiency reduces the activity of wear particles. Signaling by TLR-2 and TLR-4 through TIRAP/Mal can be activated by bacterial pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide or endogenous alarmins. To distinguish between those possibilities, we tested the hypothesis that the effects of TIRAP/Mal depend on the adherence of bacterial PAMPs to the particles.
METHODS: In vitro mRNA levels and secretion of tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 were measured after incubating wild-type and TIRAP/Mal(-/-) macrophages in the presence or absence of titanium particles with adherent bacterial debris, so-called endotoxin-free particles, or particles with adherent lipopolysaccharide. In vivo osteolysis was measured after implanting titanium particles on the calvaria of wild-type and TIRAP/Mal(-/-) mice.
RESULTS: TIRAP/Mal deficiency significantly inhibited the activity of titanium particles with adherent bacterial debris to stimulate in vivo osteolysis and in vitro cytokine mRNAs and secretion. Those effects are dependent on adherent PAMPs because removal of >99% of the adherent bacterial debris from the particles significantly reduced their activity and the remaining activity was not dependent on TIRAP/Mal. Moreover, adherence of highly purified lipopolysaccharide to the endotoxin-free particles reconstituted the activity and the dependence on TIRAP/Mal.
CONCLUSIONS: TIRAP/Mal deficiency reduces inflammatory responses and osteolysis induced by particles with adherent PAMPs. CLINICAL RELEVANCE: Our results, coupled with the genetic associations between aseptic loosening and polymorphisms within the TIRAP/Mal locus, support TLR signaling through TIRAP/Mal as one of the factors that enhances the activity of wear particles and further support the hypothesis that bacterial PAMPs likely contribute to aseptic loosening in a subset of patients.
Copyright © 2016 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26888676     DOI: 10.2106/JBJS.O.00736

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  11 in total

Review 1.  Mesenchymal stem cells in the aseptic loosening of total joint replacements.

Authors:  Jukka Pajarinen; Tzu-Hua Lin; Akira Nabeshima; Eemeli Jämsen; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2017-02-01       Impact factor: 4.396

2.  Wear Particle-induced Priming of the NLRP3 Inflammasome Depends on Adherent Pathogen-associated Molecular Patterns and Their Cognate Toll-like Receptors: An In Vitro Study.

Authors:  Givenchy W Manzano; Brian P Fort; George R Dubyak; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

3.  Lysosomal disruption by orthopedic wear particles induces activation of the NLRP3 inflammasome and macrophage cell death by distinct mechanisms.

Authors:  Brian P Fort; George R Dubyak; Edward M Greenfield
Journal:  J Orthop Res       Date:  2020-08-22       Impact factor: 3.494

4.  Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.

Authors:  Ye Gu; Zhirong Wang; Jiawei Shi; Liangliang Wang; Zhenyang Hou; Xiaobin Guo; Yunxia Tao; Xiexing Wu; Wei Zhou; Yu Liu; Wen Zhang; Yaozeng Xu; Huilin Yang; Feng Xue; Dechun Geng
Journal:  Cell Death Dis       Date:  2017-06-15       Impact factor: 8.469

5.  Particle disease really does exist.

Authors:  Jukka Pajarinen; Jiri Gallo; Michiaki Takagi; Stuart B Goodman; Bengt Mjöberg
Journal:  Acta Orthop       Date:  2017-11-16       Impact factor: 3.717

6.  Danger of frustrated sensors: Role of Toll-like receptors and NOD-like receptors in aseptic and septic inflammations around total hip replacements.

Authors:  Michiaki Takagi; Yuya Takakubo; Jukka Pajarinen; Yasushi Naganuma; Hiroharu Oki; Masahiro Maruyama; Stuart B Goodman
Journal:  J Orthop Translat       Date:  2017-06-07       Impact factor: 5.191

7.  Stevioside Prevents Wear Particle-Induced Osteolysis by Inhibiting Osteoclastogenesis and Inflammatory Response via the Suppression of TAK1 Activation.

Authors:  Jiahong Meng; Chenhe Zhou; Bin Hu; Mengmeng Luo; Yute Yang; Yangxin Wang; Wei Wang; Guangyao Jiang; Jianqiao Hong; Sihao Li; Haobo Wu; Shigui Yan; Weiqi Yan
Journal:  Front Pharmacol       Date:  2018-09-26       Impact factor: 5.810

8.  Blood cytokine pattern and clinical outcome in knee arthroplasty patients: comparative analysis 5 years after standard versus "hypoallergenic" surface coated prosthesis implantation.

Authors:  Peter Thomas; Philipp Hisgen; Hartmuth Kiefer; Ulf Schmerwitz; Andreas Ottersbach; Dominique Albrecht; Burkhard Summer; Christian Schinkel
Journal:  Acta Orthop       Date:  2018-10-29       Impact factor: 3.717

9.  Magnoflorine Suppresses MAPK and NF-κB Signaling to Prevent Inflammatory Osteolysis Induced by Titanium Particles In Vivo and Osteoclastogenesis via RANKL In Vitro.

Authors:  Zhenyu Sun; Junkai Zeng; Wenjuan Wang; Xinlin Jia; Qiang Wu; Degang Yu; Yuanqing Mao
Journal:  Front Pharmacol       Date:  2020-04-02       Impact factor: 5.810

Review 10.  Bioactive glass coatings on metallic implants for biomedical applications.

Authors:  Joy-Anne N Oliver; Yingchao Su; Xiaonan Lu; Po-Hsuen Kuo; Jincheng Du; Donghui Zhu
Journal:  Bioact Mater       Date:  2019-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.